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Background: The intramedullary skeletal kinetic distractor (ISKD) is one of the relatively recent methods
developed to overcome the complications of conventional bone lengthening methods, such as external
ﬁxators. These complications include pain, muscle transﬁxation, pin-tract infection, reduced joint mo-
tion, and prolonged ﬁxation time. However, ISKD-speciﬁc complications such as uncontrollable
lengthening and hardware failure make the outcomes of ISKD lengthening questionable. In this article,
we review published literature on the efﬁcacy and complications of the ISKD device.
Methods: A database search was conducted in PubMed, Ovid Medline, Ovid Full Text, Springer link,
EBSCO Medline, Science Direct, ISI Web of Knowledge, and Google Scholar. We included English articles
with extractable data about the study population and outcomes, reporting ISKD implantation in the
femur or tibia of skeletally mature patients. The included studies were too heterogeneous for a meta-
analysis to be performed.
Results: Fifteen of 89 potentially relevant citations were found to match the inclusion criteria. The most
common causes of limb-length discrepancy indicating an ISKD implantation were traumatic and
congenital. The average lengthening achieved, average patient discharge period, mean follow-up time,
average consolidation time and index, average distraction time and index, and number of patients
requiring additional operations as well as other outcome measures are discussed in this article. The most
common complications were runaway nail, difﬁculty in achieving lengthening, and poor bone regenerate
formation.
Conclusion: Even though the classic complications of external lengthening are virtually diminished, al-
terations to the current design of the ISKD are needed to avoid the distraction- related complications.
Risk of unplanned surgery could be minimized through proper patient selection and proper surgical
techniques.
中 文 摘 要
背景：髓內骨骼延長釘（ISKD）是為了克服常規骨骼延長的方法，如外固定支架，的併發症而新近發展的技
術。常規骨骼延長方法的併發症包括疼痛，肌肉釘住，針道感染，減少關節運動和長期的固定時間。然而，
ISKD 特有的併發症，如無法控制的延長和硬件故障都令人懷疑ISKD的療效。在本文中，我們將回顧已發表
關於ISKD療效和併發症的文獻。@gmail.com.
sociation and Hong Kong College of Orthopaedic Surgeons. Published by Elsevier (Singapore) Pte Ltd. All rights reserved.
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ISI Web of Knowledge和谷歌Scholar的數據庫搜索。我們包括那些可以取得研究群組和結果數據，並報告了
在骨骼成熟的病人身上把 ISKD植入股骨或脛骨的英語文章。
結果：在89個相關的文章中有15個符合納入標準，當中最常見的手術原因是先天性疾病和創傷。在本文中
討論我們討論了平均延長距離，患者平均住院時間，平均隨訪時間，平均骨愈合時間和指數，平均延長的時
間和指標，需要接受額外手術的患者的數量等。最常見的併發症是延長釘出位，難以達到延長目標和骨不愈
合。
結論：儘管使用ISKD使到外固定支架的典型併發症幾乎消失，目前ISKD的設計仍然需要改動，以避免延長
時出現的併發症。無計劃的手術風險可以通過適當的患者選擇和正確的手術方法來最減少。Introduction
Distraction osteogenesis is the traditional gold standard method
for correction of limb-length discrepancy. Circular external ﬁxators
(e.g., Ilizarov ﬁxator or Taylor spatial frame) or monolateral ﬁxators
(e.g., Orthoﬁx, Orthoﬁx Inc., McKinney, TX, USA or EBI, Dynaﬁx,
Parsippany, NJ, USA) provide the traditional means for inducing and
utilizing distraction osteogenesis. The most frequently experienced
complication is pin-site infection. Minor pin-tract infection rates
range from 2% to 80%, and major pin-tract infection rates that reach
23% have been reported.1,2 Soft-tissue transﬁxation by wires and
pins also can causemuscle contractures, joint stiffness, and pain.3e5
However, pain is the most common patient complaint during limb
lengthening, and may be intense during the 1st postoperative days.
Contraction of any muscle transﬁxed by a pin or wire is particularly
painful and often requires medication with narcotics. Night pain
and pain during therapy caused by stretching of the muscles and
nerves is common and can lead to loss of appetite and even
depression.5,6 The continued presence of an awkward and painful
external ﬁxation device, combined with the mental stress and
unknown outcome, can lead to variable psychological behaviours.
Neurovascular structures are also vulnerable both at the time of
screw or wire insertion as well as during distraction.7,8
Hip and knee complications, including dislocation and sublux-
ation, are often reported during and after limb lengthening. Also,
joint stiffness may occur because of long-standing contractures and
increased pressure on the joint surface during lengthening.4 Pain
often diminishes andmay inhibit functional loading andmovement
of the joints during the lengthening process, so loss of range of
motion is also common. Lengthening with external ﬁxators can
induce secondary axial deformity during or after the lengthening
process. After ﬁxator removal, refractures of the regenerated bone
can occur. The long period of external ﬁxation delays the patient's
return to normal daily activities. Clearly, it is desirable to use some
type of implantable device in limb lengthening to eliminate these
complications.
Bost and Larsen9 reported lengthening of the femur using both
an external device and an unlocked, ﬁrst-generation intra-
medullary nail to eliminate the difﬁculty of controlling the align-
ment and avoid the relatively high risk of the incidence of axial
deformity that occurs with ﬁxators alone. Paley et al10 described
the technique of lengthening over a locked intra-medullary nail,
which allows early removal of the external device after distraction.
The locked intramedullary nail provides stability during the
consolidation process, which reduces pain, lessens further pin-site
problems, and increases patient acceptance of the procedure.
Nevertheless, deep osteomyelitis can occur if pin-tract infections
spread to the tissue surrounding the intramedullary nail.11,12
Another method for safer bone lengthening is lengthening fol-
lowed by nailing, which minimizes the period of external ﬁxator
usage. It uses the application of an Ilizarov external ﬁxator with the
principle of distraction osteogenesis to achieve the desired length,and then in another surgery, the external ﬁxator is removed and an
interlocking nail is inserted. This allows the patient's bone to
consolidate within the interlocking nail alone. This method pro-
vides easier and earlier patient rehabilitation because the time of
external ﬁxator use is shortened. Nevertheless, complications such
as pin-tract infection, muscle and nerve irritation, and joint stiff-
ness are still present at the time of ﬁxator removal. Moreover, if a
concurrent infection extends in the presence of the interlocking
nail, it often leads to catastrophic deep infection.13
The goal of recent advances in the ﬁeld of limb lengthening is to
increase patient acceptance and comfort by avoiding the common
complications of the classic external ﬁxators.14 One important
achievement is the use of totally implantable intramedullary, self-
distracting lengthening nails.15e18
The Albizzia nail (DePuy, Villeurbanne, France) is a mechanically
driven device developed in the 1990s. Its lengtheningmechanism is
activated by rotations of 20 around the horizontal axis. One sig-
niﬁcant drawback is severe pain that is sometimes associated with
the large magnitude of torsion required for lengthening. This
resulted in a high incidence of either failed lengthening or the need
to return to the operating theatre and closed manipulation of the
limb under anaesthesia until distraction could recommence.
The Fitbone (Wittenstein, Igersheim, Germany) is another fully
implantable lengthening nail. Its lengthening mechanisms are
driven by an internal motor activated by an external transmitter.12
There have been promising results in the literature, with good re-
turn to function and ease of use. However, a signiﬁcant rate of
device failure has been reported, with up to 25% of patients never
achieving the desired distraction length.23
The intramedullary skeletal kinetic distractor (ISKD, Orthoﬁx
Inc., McKinney, TX, USA) is another one of those devices. It is
designed to lengthen the bone gradually as a result of small,
deliberate rotatorymovements between 3 and 9 at the osteotomy
site around the longitudinal axis of the nail. Such rotatory move-
ments can be done during normal daily activities such as walking,19
as has been originally described by Cole et al,15 and the ISKD is the
only intramedullary lengthening device approved by the Food and
Drug Administration (FDA).
Although intramedullary lengthening was introduced primarily
so that the problems of external ﬁxators can be avoided, signiﬁcant
complications have been reported with this procedure, of which
uncontrolled lengthening and nondistractible nail are the most
important.19e21 Reports of nondistracting or runaway ISKD nails are
now present, with an incidence of up to 45%.
In this systematic review, our goal is to review and discuss the
published literature that describes and criticizes the ISKD as a
method for bone lengthening in different groups of patients, to
reach a conclusion about the efﬁcacy of ISKD, help surgeons to
carefully select the appropriate indicated patients for that
procedure, and reduce the risk of unplanned surgery by avoiding
the most common surgical pitfalls that reportedly cause
complications.
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We carried out a systematic review of published studies
reporting the use of ISKD in limb lengthening. We searched eight
databases (Pub Med, Springer, EBSCO Medline, Journal Ovid Full
Text, OVID Medline Search, Science Direct, ISI Web of Knowledge,
and Google Scholar) for relevant publications. We also searched the
bibliographies of included articles to identify additional relevant
articles. References of included articles and previous reviews and
meta-analyses were reviewed to identify additional relevant arti-
cles. Between August 2012 and November 2012, routine searches
were performed with the following keywords in various combi-
nations: ISKD; intramedullary; skeletal; kinetic; distractor;
distraction; lengthening. Two reviewers (M. Abdelmohsen and M.
Amgad) independently reviewed the title and abstracts to identify
potentially relevant studies for full-text assessment. Any dis-
agreements on which studies to include were resolved by
consensus.
Inclusion criteria
We included original peer-reviewed research articles regardless
of the study design (prospective, retrospective, cross-sectional, or
interventional). Our search was limited to studies published in the
English language in a human, skeletally mature patient population.
Exclusion criteria
Exclusion criteria included studies in languages other than En-
glish; studies performed on animals; studies describing length-
ening techniques using devices other than ISKDs; and unpublished
data and abstracts for which full reports were not available.
The following data were extracted from each of the included
studies: demographic characteristics of the study population,
various prognostic parameters, and complications resulting from
the procedure. The included studies were also judged with a
checklist of potential sources of bias, as can be seen in
Table 1.15,17,18,20e30
Results
Studies that met the inclusion criteria were compiled, read, and
tabulated. Two studies by Hankemeier et al14,17 referred to the same
patient cohorts, so only one of them was included in the results
tables. Table 1 outlines the quality assessment of the included
studies in our systematic review. Table 2 lists the demographic
parameters of the patients included in each study. Many of the
studies we found reported the results of ISKD lengthening in
femora only, although the studies by Cole et al,15 Hankemeier
et al,14,17 Wang and Edwards,23 Schiedel et al,27 and Kenawey et al29
reported tibial lengthening as well regardless of the complications.
The most common causes of limb-length discrepancy necessitating
ISKD implantation were trauma, congenital causes, and cosmetic
surgical procedures. All of the patients in the included studies were
adults, with a mean age ranging from 24 years to 40 years. Table 3
compared the different complications encountered in femoral and
tibial ISKDs, wherever mentioned. Although ﬁve studies mentioned
the use of ISKD in the tibia and femora, yet only three of them
mentioned the rate of complications encountered speciﬁcally for
each.23,27,29 Table 4 summarizes the prognostic parameters of each
of the studies, where mentioned. The parameters include the mean
time to full weight bearing, mean lengthening achieved, mean
lengthening rate, mean time to patient discharge, mean follow-up
time, number and percentage of limbs in which satisfactory
lengthening was achieved, mean consolidation time and index,mean distraction index, mean intraoperative blood loss, and the
number and percentage of patients in whom additional surgical
procedures were performed.
Regarding complications, two studies reported no complications
in any of the cases treated with ISKD.17,30 Of the studies that did
mention complications, runaway nails and nondistracting nails
were most commonly reported. A study by Burghardt et al28 also
found a rather large number of cases that had hardware malfunc-
tion. Other reported complications include infection (superﬁcial
and deep), insufﬁcient bone regenerate (IBR; causing nonunion),
compartment syndrome, premature consolidation, angular defor-
mity, and joint contracture. Detailed numbers of the mentioned
ISKD complications and reported complications are summarized in
Table 5.
Discussion
Six of the 14 included studies explicitly stated their inclusion
and exclusion criteria of the study population and only eight re-
ported the consolidation and distraction indices of included cases.
Thus, in about half of the articles that met the inclusion criteria, it
was not possible for us to discernwhether any cases were excluded
based on the outcomes or whether unfavourable outcomes were
underreported. As with most research on surgical procedures, it
was not possible to blind participants and personnel to the inter-
vention, nor was there any allocation concealment in any of the
studies. These factors, among others, present potential sources of
bias that need to be taken into consideration when evaluating the
evidence presented in this review.
There are many reported advantages of using the ISKD over
conventional methods for bone lengthening. There is increased
patient comfort and an improved satisfaction with the higher
mobility that the ISKD grants. Moreover, the fact that the ISKD is
completely intramedullary means that there is virtually no risk of
pin-track infections (which may reach up to 80%), as is the case
with the Ilizarov frame. Of course, this comes with its own price, as
the intramedullary nature of the device makes it impossible to
modify or “reset” throughout the lengthening procedure. It should
not be surprising that the ability to control lengthening is
compromised in a mechanical patient-centred lengthening model.
The patient's level of activity and compliance may not be homog-
enous, and may be responsible for the variability in daily length-
ening. To account for this problem, the ISKD implant is coupled
with an external sensor that makes the patient aware of daily
changes in the nail's length.
Despite this, uncontrolled rapid lengthening of > 1.5 mm per
day (or runaway nail as it came to be known) has been repeatedly
reported in the literature as an ISKD-speciﬁc complication.20e29
This runaway nail complication was reported by most of the
included studies that did mention complications.
One possible explanation is that the patients were not
acquainted with the sensor or the device. Also, the patient's level of
activity may not be homogeneous, and may be responsible for the
variability in daily lengthening. That is why it has been argued by
Thonse et al31 that incompetent patients and patients who are not
fully capable of grasping the mechanical lengthening mechanism
should be excluded from ISKD procedures and scheduled for one of
the more conventional methods such as the Ilizarov frame. Another
possibility is that the problem is in the device itself, in which case
the design would need to be revised, as has been argued by
Kenawey et al29 and Papanna et al.22 This ﬁnding was supported by
Reynders,24 who claimed that the cause may be because a (too
sensitive) distal clutch can be activated by muscle contractions.
Indeed, Simpson et al11 found that the external ISKD sensor starts to
lose sensitivity when thigh circumference exceeds 20 cm in the
Table 1
Quality assessment of included studies
Study/potential source
of bias and rationale
for inclusion
Inclusion and exclusion
criteria clearly stated
Reporting of important
prognostic factors
(consolidation and
distraction indices,
in particular)
Blinding of participants
and personnel*
Allocation concealment* Risk of incomplete outcome data
addressed (attrition and exclusion)
Number of cases in which
the desired lengthening
was achieved
is explicitly mentioned
Rationale: to avoid
exclusion of patients
based on the outcomes
Rationale: to avoid
underreporting of
unfavourable outcomes
Rationale: to avoid placebo
and personal factors from
affecting the outcome
assessment
Rationale: to avoid biased
allocation of patients to
intervention depending on
expected outcome and/or
demographic characteristics
Rationale: dropouts and
excluded cases might affect
the overall outcome
of the study
Rationale: to avoid
underreporting
of unfavourable outcomes
Cole et al15,y No No No No Low No
Hankemeier et al17 Yes Yes No No Low Yes
Simpson et al18 No No No No Low Yes
Kenawey et al20 Yes Yes No No Low No
Kubiac et al21 Yes No No No Low No
Pappanna et al22 Yes Yes No No Low Yes
Wang and Edwards23 Yes Yes No No Low Yes
Reynders24 N/A No N/A N/A N/A N/A
Kucukkaya et al25 No Yes No No Unclear Yes
Mahboubian et al26 No Yes No No Low Yes
Schiedel et al27 No Yes No No Low Yes
Burghardt et al28 Yes No No No Low Yes
Kenawey et al29 No Yes No No Low Yes
Vitale et al30 N/A No N/A N/A N/A No
* Note that these potential sources of bias are very difﬁcult to avoid in a surgery such as intramedullary skeletal kinetic distractor implantation.
y First author is the same person who developed the intramedullary skeletal kinetic distractor, so bias toward proving its efﬁcacy and safety should be considered.
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Table 3
Studies reporting femoral and tibial elongation using the intramedullary skeletal
kinetic distractor
Wang and
Edwards23
Schiedel
et al27
Kenawey et al29
Femora Tibiae Femora Tibiae Femora Tibiae
N 11 5 58 11 45 12
Runaway nail 4 (36) 1 (20) 9 (20)
Difﬁcult-to-distract
nail
2 (18) 1 (20) 5 (9) 2 (18) 2 (4.4)
Poor regenerate
formation
3 (27) 3 (60) 10 (22.2) 1 (8.3)
Secondary failure
of ISKD (broken
or removed before
consolidation)
1 (2) 4 (36)
Premature
consolidation
4 (8.9)
Equinus contracture 2 (16.66)
Compartment
syndrome
1 (8.3)
Data are presented as n (%).
ISKD ¼ intramedullary skeletal kinetic distractor.
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deep for the sensor to detect pole changes. Statistical analysis by
Wang and Edwards23 showed that when the length of the outer nail
portion in the distal fragment is < 100 mm, runaway nail is more
likely to occur. This is consistent with the ﬁndings by Simpson
et al,18 who had seven runaway nails in 33 femoral lengthening
procedures using an ISKD nail (21%), and stated that a length of
< 80 mmwas associated with runaway nail complication. Although
Kenawey et al29 had nine runaway nails in 45 femoral lengthening
cases (20%) and none in the patients in the tibial lengthening group,
they could not support this relation. Simpson et al18 mentioned that
previous intramedullary nailing was also found to predispose to
uncontrolled lengthening.
Difﬁcult-to-distract nails is another common complication of
ISKD. Nondistracting nails were deﬁned as nails that fail to distract
in situ despite increasing the activity level and manually rotating
the lower extremities by the patients themselves or with assistance
from family members. Kubiak et al21 ﬁrst addressedwhy some nails
had difﬁculty distracting. After having three nondistracting nails in
11 femoral lengthening procedures, they explained that the use of a
straight nail such as the ISKD in a curved femur predisposes to
binding of the anterior cortices at the osteotomy site and failure to
lengthen. Simpson et al18 reported eight non-distracting nails in
their 33 femoral ISKD lengthening procedures, and subsequently
developed the previous argument by suggesting that the ease of
nail advancement is related to the length of the outer portion of the
nail situated in the distal bone fragment. The likelihood of non-
distracting nail is increased when there is a longer segment of bone
in contact with the thick segment of the nail. They found that a
length of > 125 mm is associated with difﬁcult-to-distract nails and
< 80 mm is associated with runaway nails, respectively. As
mentioned, Wang et al23 in their study demonstrated that patients
with runaway nails had a signiﬁcantly shorter segment of the thick
portion of the nail in the distal fragment than normally distracting
or difﬁcult-to-distract nails. However, perhaps because of smaller
numbers (difﬁcult-to distract nails ¼ 3), they were unable to
conﬁrm that having a longer length of the thick portion of the nail
in the distal fragment is associated with difﬁcult-to-distract nails.
Difﬁcult-to-distract nails also might be related to the design of the
ISKD.23 However, Schiedel et al27 argued, rather convincingly, that
this may not necessarily be true, given the fact that the manufac-
turer prohibits full weight bearing until there is radiological
Table 4
Prognostic parameters reported by each of the included studies (where mentioned)
Study Mean time
to full
weight
bearing (wk)
Mean lengthening
(mm)
Mean lengthening
rate (mm/d)
Mean time to
patient
discharge (d)
Mean follow-up
time (mo)
Limbs in which
target lengthening
achieved
Mean
consolidation
time (d)
Mean consolidation
index (d/mm)
Mean
distraction
index (mm/d)
Mean
intraoperative
blood loss
Patients in which
additional
operations were
performed (%)
Cole et al15 1 49 (29e110) 0.82 (0.4e1.7) 28 (12e48)
Hankemeier
et al17
10 (7e14) 31 (26e40) 10 (8e11) 14.2 (14.0e14.5) 4 (100) 80 (51e111) 2.9 (1.8e4.1) 1.2 (0.9e1.8) 230 (100e320) 3 (75)
Simpson
et al18
46 (15e80) 32 (97)
Kenawey
et al20
42.8 ± 12.9 (25e70) 1.2 ± 0.4 (0.7e2.8) 27 ± 9 (12e55) 37 (100) 3.6 ± 0.9 (1.8e6.3)* 1.1 ± 0.3*
1.7 ± 0.6y
Kubiac et al21 16 (12e26) 7 (78)
Pappanna
et al22
31 (0e60) 0.62 7 (5e9) 20.3 (8e36) 2 (66) 12.66 0.63 (0e1.25) 3 (100)
Wang and
Edwards23
35 (21e75) 16 (100) 152 (77e365) 4.87 (2.78-11.2) 0.2e2.5 6 (38)
Kucukkaya
et al25
20.5 38 (20e52) 8 (89) 2.2 (1.2e3.5) 2 (22)
Mahboubian
et al26
In 10 patients:
1.9 (1.43e2.56)
In 2 patients:
0.84 (0.75e0.93)
76 (62e93) 88 (53e100) 9.09 (1.26e51.6)
Schiedel
et al27
40.8 (10e80) 16 (6-49) 63 (91) 135 (56e477) 3.39 (2.37e9.54) 1.0 (0.1e2.5) 30 (43)
Burghardt
et al28
168 (93)
Kenawey
et al29
43 ± 16 (2e10) 1 23 ± 12 57 (100) 3.6 ± 0.96
Vitale et al30 8.5 (8e9)
Data are presented as n (%), n (range), or mean ± SD.
* In normal regenerate patients (n ¼ 29).
y In insufﬁcient regenerate group (n ¼ 8).
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Table 5
Complications reported by each of the included studies (where mentioned)
Study No. of patients No. of
inserted
ISKDs
Deep
infection
Superﬁcial
infection
Insufﬁcient bone
regenerate (causing
delayed union)
Compartment
syndrome
Runaway
nail
Jammed
nail
Difﬁcult to
distract nails
Premature
consolidation
Non-union Angular
deformity
Joint
contracture
Hardware
malfunction
Had to
abandon
technique
Cole et al15 18 20 2 (10)*
Hankemeier
et al17
4 4
Simpson
et al18
30 33 3 (9) 7 (21.2) 8 (24.2) 2 (6.06)
Kenawey
et al20
35 37 8 (21.6) 7 (18.9) 1 (2.7)
Kubiac et al21 9 11 1 (9.09) 3 (27.2) 4 (36.3)
Pappanna
et al22
3 3 1 1 (33.3) 1 1 1 1 1 1 1
Wang and
Edwards23
16 16 6 (37.5) 5 (31.2) 3 (18.7) 2 (12.5) 1 (6.2)
Reynders24 1 1 1
Kucukkaya
et al25
9 9 4 (44.4) 1 (11.1) 1
Mahboubian
et al26
11 12 1 1 1 (8.33) 1 1 1 4 (33.3)
Schiedel
et al27
69 69 7 (10.1) 6 (8.69) 7 (10.1)
Burghardt et al28 180 242y 1 (0.7) 4 (1.65) 3 (1.23) 15 (6.2)
Kenawey
et al29
53 57 1 (1.75) 12 (21) 1 9 (15.78) 1 (1.75) 4 (7.01) 2 (3.5)
Vitale et al30 2 2 1 (50)
Thonse
et al31
41ǂ 41 4 (10) 8 (20)
Data are presented as n (%).
ISKD ¼ intramedullary skeletal kinetic distractor.
* Percentages are either quoted or calculated in relative to the total number of operated limbs (inserted ISKDs) per each subsequent study.
y In the study by Burghardt et al,28 the total number of inserted ISKDs was 242 in 210 patients.
ǂ Thonse et al31 mentioned the complications in only 41 of 91 surgically treated patients.
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forces related to premature weight bearing opposed full distraction
of the ISKD nails. In order to avoid the aforementioned complica-
tions, Wang et al23 recommended an osteotomy location between
100 mm and 120 mm from the distal end of the thick segment of
the nail. Further, Kubiac et al21 recommended removal of a wedge
of bone and ensuring no cortical contact at the osteotomy site to
avoid this complication. Also, they recommended prophylactic
release of the iliotibial tract in cases in which the distraction is
planned for > 4 cm, to avoid the possible effect of the soft-tissue
tension on the nail lengthening mechanism. Simpson et al18 sup-
posed that a tight medullary canal interferes with nail distraction;
that is why they advised overreaming by 2.5e3.0 mm to facilitate
nail distraction, unless an intramedullary nail had been used pre-
viously in the femur, in which case the overreaming should be less:
perhaps 2e2.5 mm.
Another common complication with ISKD is IBR. Patients with
IBR are those who require additional surgeries to achieve union.
Regenerate failure was classiﬁed as partial failure of regenerate
formation causing partial bony defect (type I) or complete failure of
regenerate formation causing complete segmental bony defect
(type II), which is subdivided according to the length, < 3 cm (type
IIa) or > 3 cm (type IIb).29
Of 57 lengthening procedures, Kenawey et al29 reported 12 cases
(21%) of IBR formation resulting in nonunion (11 femoral and 1
tibial), and Wang and Edwards23 reported six cases of delayed
union (37.5%). In another study by Kenawey et al,29 they reported
eight cases of 37 cases (21%).20 Simpson et al18 also reported three
patients of 33 femoral lengthening procedures with IBR.
IBR formation depends on many factors; the most critical of
them being distraction rate and rhythm. Kenawey et al20 stated that
age > 30 years, smoking, length gain > 4 cm, osteotomy at the same
site of previous trauma or surgery, and acute correction of associ-
ated deformities are other important risk factors for IBR.20
The distraction rate predisposing to insufﬁcient regenerate for-
mation has been reported to be 1.5 mm/day by Kenawey et al20,29
and Wang et al,23 whereas Kubiac et al21 reported it to be 3 mm/
day. When Kenawey et al29 compared the femoral and tibial
lengthening groups to factors that may affect formation and healing
of bone regenerate, they found the rate of poor bony regenerate to
be less with tibial lengthening cases compared to femoral cases.
Their explanation was attributed to the fact that the femoral group
had signiﬁcantly higher distraction rates than the tibial group. Six
of nine patients with runaway nails had IBR in their study. No
statistically signiﬁcant differences were found between both
groups regarding age, percentages of smokers, number of
concomitant corrections of associated deformities, performing
osteotomies at the same level of a previous trauma or surgery, or
the magnitude of length gain. Furthermore, no signiﬁcant differ-
ence could be attributed to the etiology of shortening.
Wang and Edwards23 found no statistically signiﬁcant difference
between femoral and tibial lengthening in terms of length gained,
proportion of runaway nails, and proportion of difﬁcult-to-distract
nails. Nevertheless, they found a greater proportion of poor
regenerate formation in the tibiae in comparison with the femora.
They claimed that the number of previous surgical procedures on
the lengthened bone was signiﬁcantly associated with an increased
likelihood of poor bone regenerate formation. This, they proposed,
may be caused by poor bone quality and blood supply to the sur-
rounding tissues, in addition to extensive scarring. That is why
Wang and Edwards23 advocate the use of traditional lengthening
with Ilizarov ﬁxation when dealing with patients who have had
multiple prior open procedures.
The designer of the ISKD nail, Cole et al,15 included in their
article a description of 14 cases of tibial distraction using the device.However, consolidation index, rates of poor regeneration, and other
complications were not mentioned.
Regarding frank device failure, which is deﬁned as breakage of
the nail or absolute failure of the mechanism to lengthen despite a
complete osteotomy, it can result from either a manufacturing
defect of the nail or a biologically related situation. A study by
Burghardt et al28 speciﬁcally studied the hardware failure compli-
cation in a large number of surgically treated limbs (210 limbs, 242
ISKDs) and found a rather large number of cases that had hardware
malfunction. They reported 15 cases of hardware malfunction in 12
of 180 patients representing an overall failure rate of 6.2%, with
fracture of the device occurring in 10 of the 15 failures; subsequent
nonunion developed in three of these 10 nails, which presumably
caused an overloading of the nail and resulted in breakage. A total
of 14 lengthening procedures were performed in the femur (8 of
which received femoral nails and 6 received tibial nails) and one
was performed in the tibia. Details of the 15 reported failures were
as follows: in four cases, a disengaged key ring was noted upon
device removal; in four cases lengthening failed because of an error
in the manufacturer's assembly; in two cases there were mirror-
image nail fractures of the female component resulting in torsion
overload; in two cases the key ring and female part broke after
nonunion; in two cases there was nonunion caused by torsion
overload; in one nail, the lengthening mechanism jammed as a
result of being forcefully implanted when it deviated from the
prereamed canal into an unreamed portion of the distal meta-
physis. This was recognized during the surgical procedure, and the
ISKD was immediately exchanged for another nail that functioned
correctly. This damage demonstrates that a mechanically complex
nail requires more delicate handling than a standard intra-
medullary nail.
When breakage occurred before the bone was fully consoli-
dated, it is possible that the nail was damaged through an overload
during the vulnerable period of the lengthening process. If this is
the case, it may be prudent to extend the period before allowing full
weight bearing. Additionally, patients should be advised to restrict
weight bearing to< 50 lb (22.7 kg) until sufﬁcient consolidation has
taken place. To avoid these complications, patients with delayed
consolidation need special attention. Burghardt et al28 believe full
weight bearing should be avoided until solid radiological healing
has been achieved. In the event of nonunion, consideration should
be given to bone grafting and nail exchange earlier than in those
with normal trauma.
Because most failures in this study were recognized radiologi-
cally at follow-up visits or during removal of the nail, special
attention should be paid to the early recognition of implant frac-
tures on radiography. Retrieved nails should undergo a careful in-
spection by the surgeon for visible defects and to ensure that no
broken pieces remain in the limb after surgery.
Despite these failures, Burghardt et al28 stated that the ISKD is
well constructed and is acceptably reliable. Although 15 failures
were observed, only three patients required an additional surgical
procedure to gain the desired length. Furthermore, none of the
failures resulted in catastrophic complications or led to loss of
length.
It is worth mentioning that despite the large number of patients
included in the study of Burghardt et al,28 the study discusses only
the hardware malfunction complication in 15 patients. No other
complications regarding distraction or unionwere mentioned. That
is why the interpretation of the study by Burghardt et al28 in our
review tables was conﬁned only to speciﬁc few parts in our tables.
Among the important publications we found was a study by
Thonse et al,31 reporting their experience with 116 ISKD implant
cases that were treated over the course of 4 years. An early review
of follow-up of the ﬁrst 41 patients showed that 70% of these
A.N. Mahmoud et al. / Journal of Orthopaedics, Trauma and Rehabilitation 18 (2014) 69e78 77patients experienced distraction that progressed normally. Twenty
percent (8 of 41 patients) had a difﬁcult time inducing distraction,
and 10% (4 of 41 patients) experienced distraction that progressed
too rapidly. Even though they did not report demographic charac-
teristics or prognostic parameters of their patient cohort, they re-
ported a valuable set of general inclusion and exclusion criteria of
patients regarding ISKD lengthening. Important classic exclusion
criteria include skeletal immaturity, limb-length discrepancy
< 20 mm or > 80 mm, active infection, unstable hip/knee joints,
metabolic diseases, systemic disease, and smoking. Furthermore, it
has to ascertained that bones are of adequate length and that the
medullary canals have the appropriate diameter needed to
accommodate the ISKD implant. With the femur, the nail is 255mm
long and has a diameter of 12.5 mm (reamed to 14.5 mm). With the
tibia, the nail is 215 mm long and has a diameter of 10.8 mm
(reamed to 12.5 mm).
Although the ISKD has been approved by the FDA, the UK Na-
tional Institute for Health and Clinical Excellence (NICE) did not
recommend the use of intramedullary lengthening devices after
examining the published literature.32 Schiedel et al27 concluded, in
contrast to the NICE recommendations, that the overall reliability of
the ISKD in the femur was good, with 52 of 58 lengthening pro-
cedures (98%) being successful. They stated that ISKD can be rec-
ommended with good patient selection and in pure lengthening up
to 5 cm without associated correction of axial deformity. In the
tibia, although the implant functioned in nine of 11 cases, suc-
cessful treatment was obtained in only ﬁve. The tibia results
detracted from the overall success of this implant, with 57 of 69
patients (83%) reaching their goal, but it is still comparable with
other experiences with this implant.
We agree with the NICE recommendations for the current ISKD
design, but we believe that proper patient selection, surgical
technique, strict follow-up, and patient compliance along with
some technical modiﬁcation of the current designwill help to easily
overcome the aforementioned complications.
For tibial ISKD, patients who underwent multiple surgical
intervention and patients with unfavorable soft tissue conditions
and extensive scarring in whom the healing power and local blood
supply are questionable should be excluded from the procedure.
For femoral ISKD, patients with excessively curved femora should
be excluded from the procedure and shifted to one of the con-
ventional methods.
Regarding the technical modiﬁcations related to the implant
itself, revisions of the current ISKD design are recommended so that
the risk of unplanned surgery could be minimized. These revisions
may include slight curvature of the femoral ISKD components to
withstand the femoral bowing without intervening with the
lengthening mechanism. Also, as previously mentioned that the
risk of runaway nail is directly proportionate to the length of the
outer portion of the nail inside the distal fragment, the outer
portion of the nail could be lengthened more, providing a wide
longitudinal opening on both sides to accommodate the two distal
screws of the inner portion freely and allow its distraction and the
3e9 of rotation without or with minimal impingement. Also,
revision of manufacturing of the sensor should be done to over-
come the loss of sensor sensitivity in patients with thigh circum-
ference < 20 cm. Another possible modiﬁcation is the revision of
the distal clutcherod relationship, so that the too-sensitive distal
clutch could be sensitive only to the physiologic movements rather
than any muscle contractions. In addition, revision of assembly of
the junction between the nail telescopic mechanisms, which is the
weakest portion of the nail where most cases of nail fracture occur,
should be considered. After reviewing the literature we believe that
these modiﬁcations, in addition to patient selection and follow-up,
will solve most of the ISKD related complications.Conclusion
The ISKD offers the advantages of early rehabilitation, early full
weight bearing, and excellent functional results. It also provides
stable intramedullary ﬁxation and avoids the inevitable disadvan-
tages of external ﬁxators, such as pin-track infection, painful scars,
and discomfort caused by long-term use of the device.
Disadvantages of the ISKD include difﬁculties in controlling the
distraction, especially during femoral lengthening. Distraction rates
> 1.5 mm/day are a risk factor for runaway nail and IBR formation
with subsequent delayed union. In addition, difﬁcult-to-distract
nails and poor bone regenerate formation are other complications
that occur with inappropriate patient selection and poor surgical
technique. That is why, after analysing the previous studies, sur-
gical technique, patient education, and strict follow-up along with
some technical modiﬁcations of the current design of ISKDwill help
to avoid the related complications, and subsequently provide the
surgeon another reliable option for bone lengthening with good
efﬁcacy and improved patient comfort.Conﬂicts of interest
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